ABOUT

Aruwon was founded by Dr. Chris Redhead in 2009. Following an early career as a cell biologist, Chris spent more than 12 years providing top-ranked equity research on leading UK/European small and mid-cap biopharmaceutical, healthcare and diagnostic companies and was involved in a broad range of both public and private fund raisings as well as M&A. Until 2024, Chris was also a consulting analyst for goetzpartners securities Ltd providing equity analysis.